Account
Pernod Ricard AOR retains Maxus India
MUMBAI: Pernod Ricard has retained Maxus India for media planning, buying and marketing responsibilities in India.
Maxus has been working with Pernod Ricard over the last decade. The multi-agency pitch saw participation from other leading agencies along with the incumbent agency Maxus. The account will continue to be handled out of Delhi office led by Navin Khemka.
Maxus South Asia managing director Kartik Sharma said, “This is a moment of pride for all of us and such wins ensure we continue to deliver the best for our brands. It (our retention) is extremely satisfying and a validation of our work. I am grateful to Pernod Ricard for reposing faith in us and continuing our decade-old relationship. We eagerly look forward to the next leg of this partnership.”
Pernod Ricard India business development executive director Sumeet Lamba said, “Maxus’s superior understanding of the category and its nuances has helped us in meeting our brand marketing goals. We are confident that they will continue to be an effective partner in the years to come.”
Maxus managing director Navin Khemka said, “We are committed to enhance our cutting-edge creative thinking on Pernod Ricard. Together, we have created iconic brands that we are proud of and we are confident of delivering unmatched media value, going forward.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
